Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Neil Kumar
Biotech
BridgeBio's phase 2 data provides hope for rare disease drug
The biotech may be on a new upward trajectory as it unveiled positive data from 13 patients taking a drug to treat low calcium levels.
Gabrielle Masson
Jun 14, 2022 8:20am
BridgeBio's CEO on staying alive, 'motherhood and apple pie'
May 26, 2022 5:00am
BridgeBio's en route to proving out its 'Moneyball' model: CEO
Sep 29, 2020 7:00am
CEO Kumar on BridgeBio's model and where else it could work
Jun 10, 2020 8:40am
